Altered gene expression in drug-resistant human breast cancer cells.

作者: K. Wosikowski , G. J. P. L. Kops , S. E. Bates , M. Saceda , D. Schuurhuis

DOI:

关键词:

摘要: It is increasingly recognized that drug-resistant cells undergo transitions not directly linked to "classical" drug resistance. We examined the expression of growth factors, factor receptors, and estrogen receptor in 17 2 revertant human breast cancer sublines provide an understanding phenotypic changes occur how these could affect biology cell. These were derived from five parental cell lines (MCF-7, ZR75B, T47D, MDA-MB-231, MDA-MB-453). The was absent or decreased 6 15 resistant MCF-7, T47D sublines. Increases as much 49-fold compared levels observed transforming alpha, epidermal receptor, c-erbB2, and/or c-erbB3 mRNA 14 Altered amphiregulin insulin-like factor-I nine four sublines, respectively. No major alterations c-erbB4 expression. Few two receptor-negative cells. Higher phosphotyrosine residues detected a subset indicating increased tyrosine kinase activity Interestingly, rates all despite up-regulated factor-related gene Taken together, data suggest loss pathway genes, rate regularly Although we do know whether altered genes cause consequence reduced rate, it well established confers serve initiate, support, extend

参考文章(54)
H Kreipe, F Boege, A Andersen, S Jensen, R Zeidler, Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies. American Journal of Pathology. ,vol. 146, pp. 1302- 1308 ,(1995)
Y N Chen, L A Mickley, A M Schwartz, E M Acton, J L Hwang, A T Fojo, Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein. Journal of Biological Chemistry. ,vol. 265, pp. 10073- 10080 ,(1990) , 10.1016/S0021-9258(19)38781-2
D. L. Herrin, G. W. Schmidt, Rapid, reversible staining of northern blots prior to hybridization. BioTechniques. ,vol. 6, pp. 196- ,(1988)
James W. Karaszkiewicz, Sung Ae Lee, Wayne B. Anderson, Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Research. ,vol. 52, pp. 3750- 3759 ,(1992)
L A Mickley, S E Bates, N D Richert, S Currier, S Tanaka, F Foss, N Rosen, A T Fojo, Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents Journal of Biological Chemistry. ,vol. 264, pp. 18031- 18040 ,(1989) , 10.1016/S0021-9258(19)84675-6
O Sartor, J H Sameshima, K C Robbins, Differential association of cellular proteins with family protein-tyrosine kinases. Journal of Biological Chemistry. ,vol. 266, pp. 6462- 6466 ,(1991) , 10.1016/S0021-9258(18)38140-7
M. Saceda, C. Knabbe, R.B. Dickson, M.E. Lippman, D. Bronzert, R.K. Lindsey, M.M. Gottardis, M.B. Martin, Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-O-tetradecanoylphorbol-13-acetate. Journal of Biological Chemistry. ,vol. 266, pp. 17809- 17814 ,(1991) , 10.1016/S0021-9258(18)55199-1
Gabriel Hortobagyi, Margot Finders, Dennis Johnston, Verena Hug, Use of Growth-stimulatory Hormones to Improve the in Vitro Therapeutic Index of Doxorubicin for Human Breast Tumors Cancer Research. ,vol. 46, pp. 147- 152 ,(1986)
Franz B. Thiebaut, Doreen K. Hom, Paul A. Andrews, Alakananda Basu, Alan Eastman, John S. Lazo, Stephen B. Howell, Seiji Isonishi, Stephen C. Mann, Expression of the c-Ha-ras Oncogene in Mouse NIH 3T3 Cells Induces Resistance to Cisplatin Cancer Research. ,vol. 51, pp. 5903- 5909 ,(1991)
M.M. Cornwell, D.E. Smith, A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase. Journal of Biological Chemistry. ,vol. 268, pp. 15347- 15350 ,(1993) , 10.1016/S0021-9258(18)82262-1